Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Liver Diseases

  Free Subscription


1 Am J Gastroenterol
6 Biochem Biophys Res Commun
3 BMC Cancer
1 BMC Gastroenterol
1 Eur Radiol
5 Gut
3 Hepatology
2 J Gastroenterol Hepatol
4 J Hepatol
1 J Pediatr
1 Semin Liver Dis
5 Transplant Proc
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

  1. REIG A, Sese P, Pares A
    Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  2. LI Y, Hao B, Muhammad I, Zhang Y, et al
    Acetaminophen-induced reduction in glutathione-S-transferase A1 in hepatocytes: A role for hepatic nuclear factor 1alpha and its response element.
    Biochem Biophys Res Commun. 2019 Jun 20. pii: S0006-291X(19)31136.
    PubMed     Text format     Abstract available

  3. XU F, Wang B, Liu M, Liu T, et al
    A long non-coding RNA TSLD8 inhibits hepatocellular carcinoma by stabilizing WWOX.
    Biochem Biophys Res Commun. 2019 Jun 20. pii: S0006-291X(19)31168.
    PubMed     Text format     Abstract available

  4. MENG X, Lu P, Fan Q
    Retraction notice to "miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN" [Biochem. Biophys. Res. Commun. 470/1 (2016) 187-191].
    Biochem Biophys Res Commun. 2019;515:727.
    PubMed     Text format    

  5. LI T, Wen L, Cheng B
    Cordycepin alleviates hepatic lipid accumulation by inducing protective autophagy via PKA/mTOR pathway.
    Biochem Biophys Res Commun. 2019 Jun 23. pii: S0006-291X(19)31244.
    PubMed     Text format     Abstract available

  6. CHEN J, Yang T, Song S, Liu Q, et al
    Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation.
    Biochem Biophys Res Commun. 2019 Jun 22. pii: S0006-291X(19)31239.
    PubMed     Text format     Abstract available

  7. CUI W, Li Y, Xu K, Chen G, et al
    Retraction notice to "miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA" [Biochem. Biophys. Res. Commun. 479/4 (2016) 901-906].
    Biochem Biophys Res Commun. 2019;515:732.
    PubMed     Text format    

    BMC Cancer

  8. KLEMENT RJ, Abbasi-Senger N, Adebahr S, Alheid H, et al
    The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    BMC Cancer. 2019;19:173.
    PubMed     Text format     Abstract available

  9. NAKAMURA N, Hatano E, Iguchi K, Sato M, et al
    Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    BMC Cancer. 2019;19:621.
    PubMed     Text format     Abstract available

  10. RUIZ A, Sebagh M, Saffroy R, Allard MA, et al
    Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection.
    BMC Cancer. 2019;19:169.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  11. HE L, Ye X, Ma J, Li P, et al
    Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy.
    BMC Gastroenterol. 2019;19:101.
    PubMed     Text format     Abstract available

    Eur Radiol

  12. LANGENBACH MC, Vogl TJ, von den Driesch I, Kaltenbach B, et al
    Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Eur Radiol. 2019 Jun 24. pii: 10.1007/s00330-019-06297.
    PubMed     Text format     Abstract available


  13. ZHANG Q, Lou Y, Yang J, Wang J, et al
    Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.
    Gut. 2019 Jun 21. pii: gutjnl-2019-318912. doi: 10.1136/gutjnl-2019-318912.
    PubMed     Text format     Abstract available

    Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma?
    Gut. 2019 Jun 26. pii: gutjnl-2019-319084. doi: 10.1136/gutjnl-2019-319084.
    PubMed     Text format    

  15. ALFERINK LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, et al
    Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.
    Gut. 2019;68:1088-1098.
    PubMed     Text format     Abstract available

  16. PINYOL R, Montal R, Bassaganyas L, Sia D, et al
    Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
    Gut. 2019;68:1065-1075.
    PubMed     Text format     Abstract available

  17. HYUN J, Oh SH, Premont RT, Guy CD, et al
    Dysregulated activation of fetal liver programme in acute liver failure.
    Gut. 2019;68:1076-1087.
    PubMed     Text format     Abstract available


  18. PAPATHEODORIDI AM, Chrysavgis L, Koutsilieris M, Chatzigeorgiou A, et al
    The role of senescence in the development of non-alcoholic fatty liver disease and progression to non-alcoholic steatohepatitis.
    Hepatology. 2019 Jun 23. doi: 10.1002/hep.30834.
    PubMed     Text format     Abstract available

  19. CHOUDHARY NS, Saraf N, Saigal S, Soin AS, et al
    Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis.
    Hepatology. 2019 Jun 27. doi: 10.1002/hep.30837.
    PubMed     Text format     Abstract available

  20. MOUSA OY, Malhi H, Russo N, Jesudian A, et al
    Hepatology Highlights.
    Hepatology. 2019;70:1-4.
    PubMed     Text format    

    J Gastroenterol Hepatol

  21. ZHU S, Du L, Xu D, Lu Z, et al
    Ascitic Fluid Total Protein, a useful marker in non-portal hypertensive ascites.
    J Gastroenterol Hepatol. 2019 Jun 27. doi: 10.1111/jgh.14768.
    PubMed     Text format     Abstract available

  22. REKIK S, Allaire M, Mumana A, Guyot E, et al
    Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.
    J Gastroenterol Hepatol. 2019 Jun 24. doi: 10.1111/jgh.14763.
    PubMed     Text format     Abstract available

    J Hepatol

  23. MAJUMDAR A, Roberts SK, Pilcher D
    Are liver transplant centres critical for the critically ill patient with cirrhosis?
    J Hepatol. 2019 Jun 21. pii: S0168-8278(19)30288.
    PubMed     Text format    

  24. DURAND F, Pavesi M, Cheung R
    Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand?
    J Hepatol. 2019 Jun 19. pii: S0168-8278(19)30304.
    PubMed     Text format    

  25. RYAN MC, Zelber-Sagi S
    Hepatic fat: Pathogenic trigger or passenger?
    J Hepatol. 2019 Jun 18. pii: S0168-8278(19)30302.
    PubMed     Text format    

  26. BORST K, Graalmann T, Kalinke U
    Reply to: "Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers".
    J Hepatol. 2019 Jun 18. pii: S0168-8278(19)30298.
    PubMed     Text format    

    J Pediatr

  27. KHAN S, Balistreri W
    50 Years Ago in TheJournal ofPediatrics: Fatal Neonatal Hepatic Steatosis: A New Familial Disorder.
    J Pediatr. 2019;210:145.
    PubMed     Text format    

    Semin Liver Dis

  28. AFIFY AY, Ibrahim SA, Aldamsisi MH, Zaghloul MS, et al
    Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of Rivalry.
    Semin Liver Dis. 2019 Jun 26. doi: 10.1055/s-0039-1688442.
    PubMed     Text format     Abstract available

    Transplant Proc

  29. NAGY G, Gorog D, Kobori L, Mihaly E, et al
    Abdominal Compartment Syndrome After Liver Transplant in Drug-Induced Acute Liver Failure: A Case Report.
    Transplant Proc. 2019;51:1289-1292.
    PubMed     Text format     Abstract available

  30. KORDA D, Doros A, Piros L, Gerlei Z, et al
    Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
    Transplant Proc. 2019;51:1251-1253.
    PubMed     Text format     Abstract available

  31. EGELI T, Unek T, Agalar C, Ozbilgin M, et al
    Survival Outcomes After Liver Transplantation in Elderly Patients: A Single-Center Retrospective Analysis.
    Transplant Proc. 2019;51:1143-1146.
    PubMed     Text format     Abstract available

  32. ACAR S, Donmez G, Acar RD, Kavlak ME, et al
    Idiopathic Pulmonary Hypertension After Liver Transplantation.
    Transplant Proc. 2019 Feb 8. pii: S0041-1345(18)31722.
    PubMed     Text format     Abstract available

  33. EGELI T, Unek T, Agalar C, Ozbilgin M, et al
    The Analysis of Posthepatectomy Liver Failure Incidence and Risk Factors Among Right Liver Living Donors According to International Study Group of Liver Surgery Definition.
    Transplant Proc. 2019;51:1121-1126.
    PubMed     Text format     Abstract available


  34. VICTOR DW 3RD, Monsour HP Jr, Boktour M, Lunsford K, et al
    Outcomes of Liver transplantation for hepatocellular carcinoma (HCC) beyond the University of California San Francisco (UCSF) criteria: a single center experience.
    Transplantation. 2019 Jun 18. doi: 10.1097/TP.0000000000002835.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.